Des-gamma-carboxy prothrombin (DCP) level is a strong factor to predict the prognosis of advanced stage of hepatocellular carcinoma patients treated by chemolipiodolization or chemotherapy only.

被引：0
|
作者：
Ohnishi, H
Sakaguchi, K
Nishda, T
Iwadou, S
Shoji, B
Tanaka, H
Nakamura, S
Kobayashi, Y
Noose, K
Shiratori, Y
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A453 / A453
页数：1
相关论文
共 50 条
  • [21] CHANGES OF PLASMA DES-GAMMA-CARBOXY PROTHROMBIN LEVELS IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA IN RESPONSE TO VITAMIN-K
    FURUKAWA, M
    NAKANISHI, T
    OKUDA, H
    ISHIDA, S
    OBATA, H
    CANCER, 1992, 69 (01) : 31 - 38
  • [22] Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapy
    Saeki, Issei
    Shimose, Shigeo
    Tomonari, Tetsu
    Ito, Takanori
    Tani, Joji
    Takeuchi, Yasuto
    Yoshioka, Naoki
    Naito, Takehito
    Takeuchi, Mamiko
    Kakizaki, Satoru
    Hatanaka, Takeshi
    Sasaki, Kyo
    Yasunaka, Tetsuya
    Sakata, Masahiro
    Iwamoto, Hideki
    Itano, Satoshi
    Shirono, Tomotake
    Tanabe, Norikazu
    Yamamoto, Takafumi
    Kanayama, Yuki
    Naganuma, Atsushi
    Nishina, Sohji
    Otsuka, Motoyuki
    Kobara, Hideki
    Kawashima, Hiroki
    Takayama, Tetsuji
    Kawaguchi, Takumi
    Yamasaki, Takahiro
    Takami, Taro
    PLOS ONE, 2024, 19 (09):
  • [23] SIGNIFICANCE OF SERUM ALPHA-FETOPROTEIN (AFP) AND DES-GAMMA-CARBOXY PROTHROMBIN (DCP) LEVELS TO IDENTIFY TREATMENT FAILURE AND CONTRAINDICATION FOR HEPATECTOMY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
    Yamamoto, Kentaroh
    Imamura, Hiroshi
    Aoki, Taku
    Beck, Yoshifumi
    Hasegawa, Kiyoshi
    Sugawara, Yasuhiko
    Makuuchi, Masatoshi
    Kokudo, Norihiro
    HEPATOLOGY, 2010, 52 (04) : 1192A - 1192A
  • [24] Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma
    Aoyagi, Y
    Oguro, M
    Yanagi, M
    Mita, Y
    Suda, T
    Suzuki, Y
    Hata, K
    Ichii, K
    Asakura, H
    CANCER, 1996, 77 (09) : 1781 - 1786
  • [25] Novel method to measure serum levels of des-gamma-carboxy prothrombin for hepatocellular carcinoma in patients taking warfarin: A preliminary report
    Toyoda, Hidenori
    Kumada, Takashi
    Osaki, Yukio
    Tada, Toshifumi
    Kaneoka, Yuji
    Maeda, Atsuyuki
    CANCER SCIENCE, 2012, 103 (05) : 921 - 925
  • [26] THE EFFECTS OF VITAMIN-K ON THE GENERATION OF DES-GAMMA-CARBOXY PROTHROMBIN (PIVKA-II) IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA
    SAKON, M
    MONDEN, M
    GOTOH, M
    KOBAYASHI, K
    KANAI, T
    UMESHITA, K
    ENDOH, W
    MORI, T
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1991, 86 (03): : 339 - 345
  • [27] Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma
    Lee, Myoung Ha
    Kim, Seung Up
    Kim, Do Young
    Ahn, Sang Hoon
    Choi, Eun Hee
    Lee, Kwang Hun
    Lee, Do Yun
    Seong, Jinsil
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Park, Jun Yong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (02) : 313 - 322
  • [28] Measurement of serum levels of des-gamma-carboxy prothrombin zn patients with hepatocellular carcinoma by a revised kit with increased sensitivity.
    Okuda, H
    Nakanishi, T
    Takatsu, K
    Hashimoto, E
    Saito, A
    Hayashi, N
    Watanabe, K
    Naraki, T
    HEPATOLOGY, 1996, 24 (04) : 1386 - 1386
  • [29] Diagnostic value of Lens culinaris agglutinin isoform 3 fraction (AFP-L3%) and des-gamma-carboxy prothrombin (DCP) for the diagnosis of hepatocellular carcinoma in cirrhotic patients
    Romeo, R.
    Sangiovanni, A.
    Iavarone, M.
    Vavassori, S.
    Della Corte, C.
    Colombo, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] The Characteristics and Prognosis of Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin Double-Negative Hepatocellular Carcinoma at Baseline in Higher BCLC Stages
    Nagahara, Takakazu
    Sugihara, Takaaki
    Kihara, Takuya
    Ikeda, Suguru
    Hoshino, Yoshiki
    Matsuki, Yukako
    Sakaguchi, Takuki
    Kurumi, Hiroki
    Onoyama, Takumi
    Takata, Tomoaki
    Matono, Tomomitsu
    Yamaguchi, Naoyuki
    Isomoto, Hajime
    CANCERS, 2023, 15 (02)
12345